
Jan 16 (Reuters) - SEC Filing:
AGOMAB THERAPEUTICS FILES FOR US IPO - SEC FILING
AGOMAB THERAPEUTICS NV SAYS J.P. MORGAN ,MORGAN STANLEY, LEERINK PARTNERS AND VAN LANSCHOT KEMPEN ARE UNDERWRITERS TO IPO
AGOMAB THERAPEUTICS NV: APPLIED TO LIST ADSS ON NASDAQ, UNDER SYMBOL “AGMB”
AGOMAB THERAPEUTICS NV: 5.73% OF COMMON SHARES BENEFICIALLY OWNED BY PFIZER BEFORE OFFERING
AGOMAB THERAPEUTICS NV: 7.48% OF COMMON SHARES BENEFICIALLY OWNED BY SANOFI FOREIGN PARTICIPATIONS B.V BEFORE OFFERING
Source text: [ID:n0001104659-26-004558]
Further company coverage: [ ]